BioNTech SE is 13.5x more valuable than RECURSION PHARMACEUTICALS, INC. by market capitalization ($21.79 B vs $1.61 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | RXRX | BNTX |
|---|---|---|
| Market cap | $1.61 B | $21.79 B |
| US-listed rank | #2257 | #587 |
| Revenue (latest FY) | $74.68M | - |
| Net income (latest FY) | -$644.76M | - |
| Net margin | -863.4% | - |
| SEC filings | 908 | 548 |
BioNTech SE is 13.5x more valuable than RECURSION PHARMACEUTICALS, INC. by market capitalization ($21.79 B vs $1.61 B).
Full pages: RECURSION PHARMACEUTICALS, INC. and BioNTech SE, or browse the full rankings.